Nexien BioPharma Inc (QB) (NXEN) Fundamentals

Nexien BioPharma Inc. is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals, in accordance with U.S. Food and Drug Administration ('FDA') pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders. Nexien BioPharma's drug development strategy consists of: A. The determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations; B. Conducting "freedom to operate" investigations on these conditions; C. The preparation of patent applications and the prosecution of such application and/or the licensing of existing patents; D. Identifying the regulatory pathway with the FDA; and E. Proceeding with pre-clinical and clinical development activities in accordance with FDA protocols for submission to obtain approval for the particular product(s).
Share Info
Market Cap$ 3,207,676
Shares Authorized200,000,000
Shares Outstanding60,522,196
Shares Outstanding Date07/19/2022
Shareholder Count701
Shareholder Count Date10/12/2021
Float Date12/31/2021
Short Interest11,471
Short Interest Date07/29/2022
Reporting Info
Reporting StatusSEC Reporting
Audit StatusYes
Auditor Address363 N. Sam Houston Parkway E.
Suite 650
Houston, Texas 77060
Auditor Website
IR Firm-
IR Firm Address-
IR Firm Website-
Legal CounselDoida Law Group
Legal Counsel Address8480 E. Orchard Road
Suite 2000
Greenwood Village, Colorado 80111
Legal Counsel Website
Fiscal Year End6/30
ADR Ratio-
Transfer AgentStandard Registrar & Transfer Co., Inc.
Transfer Agent Address440 East 400 South
Suite 200
Salt Lake City, UT 84111
Depository Website
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:NXEN
OTC Market TierOTCQB
Security TypeOrdinary Shares
CIK Number0001625288
Address4340 East Kentucky Avenue
Suite 206
Glendale, Colorado 80246
Phone(303) 495-7583
Fax #212-658-9867
SIC Code / Description2834 / Pharmaceutical preparations
Key ExecutivesSecurities Counsel - Fay Matsukage
COO - Robert Goldfarb
CEO - Richard Greenberg
Dir. - Lindy Snider
CFO - Evan Wasoff
Number of Employees3
Incorporation StateDelaware
Incorporation CountryUSA
Incorporation Year1952

Your Recent History
Nexien Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.